Blog

Aaron Goodman/X

Oct 6, 2024, 12:18

Aaron Goodman: CMV drugs!

Aaron Goodman posted the following on X:

“CMV drugs!

Ganciclovir
GCV-phos -> DNA
WBC

Foscarnet
Mimic of pyrophosphate interferes with exchange in DNA
Nephrotoxicity, electrolytes

Cidofovir CDV-phos -> DNA
Nephrotoxicity/Fanconi syndrome

Letermovir = PPx
Targets CMV DNA terminase (pUL56)
Limited toxicity.”

Aaron Goodman: CMV drugs!

Source: Aaron Goodman/X

Aaron Goodman is a Hematologist/ Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.

Aaron Goodman cancer CDV-phos Cidofovir CMV DNA terminase CMV drugs DNA electrolytes Fanconi syndrome Foscarnet Ganciclovir GCV-phos Letermovir nephrotoxicity OncoDaily Oncology pyrophosphate WBC

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer